November 8, 2010 – Patient enrollment has begun in a trial looking at a new system for patients undergoing diagnostic angiography procedures through the femoral artery. The RECITAL study will observe the safety and effectiveness of the Arstasis One access system. It is expected to enroll up to 500 patients in at least seven U.S. hospitals.

November 8, 2010 – A new aortic extension has been implanted in a clinical setting for the first time. The Ventana fenestrated stent graft, by Endologix, was implanted at Auckland City Hospital in Auckland, New Zealand.

November 5, 2010 - A study performed by investigators from the Emergency Department of the Cleveland Clinic Foundation found that a noninvasive cardiac output monitor (NICOM) system is effective in identification of acute heart failure (AHF). The system, by Cheetah Medical, is also effective in differentiating AHF from other acute situations with similar clinical presentations.

November 5, 2010 – ST Cardio was awarded nearly $250,000 in a grant under the Qualifying Therapeutic Discovery Project Program. The grant is related to the company’s Z6 Cardiac Stimulator.

The grant, which totaled $244,479, is given to projects that can result in new therapies that treat unmet needs or reduce the long-term growth of healthcare costs.

November 5, 2010 – Cardiovascular Systems Inc. (CSI) will pay $1 million to settle an employment lawsuit with ev3, which is now part of Covidien.

The litigation stems from a lawsuit ev3 originally filed in 2007 related to ev3 employees who joined Cardiovascular Systems Inc.

November 5, 2010 – The National Heart, Lung, and Blood Institute has awarded the University of Illinois at Chicago (UIC) more than $12 million to investigate the acquired and familial causes of heart failure. The goal is to identify markers for diagnosis and targets for cures.

November 5, 2010 – The final patient has been enrolled in a trial studying a balloon-expandable covered stent for those with occlusive disease of the iliac artery. The iCARUS trial is investigating the iCast stent, made by Atrium Medical.

November 5, 2010 – Stereotaxis has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program. Enacted under the Patient Protection and Affordable Care Act of 2010, the program targets projects that address unmet needs, reduce long-term healthcare costs and produce new therapies.

November 5, 2010 – New research shows that novel drug-coated balloon technology is being adopted in niche applications throughout Europe. The research, from the Millenium Research Group, also found that the market will continue to grow as physicians increasingly use the balloons when other devices are not suitable.

November 5, 2010 - The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the latest version of a cardiovascular ultrasound system. The GE Healthcare Vivid E9 Breakthrough 2011 (BT11) is built for 4-D imaging and features elements designed to help improve image quality, quantification and workflow.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now